TG4010

 

Topic mentions per year

Topic mentions per year

2003-2018
02420032018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND MUC1 is a tumour-associated antigen expressed by many solid tumours, including non-small-cell lung cancer. TG4010 is a… (More)
Is this relevant?
2012
2012
TG4010 is a therapeutic cancer vaccine based on a viral vector, a modified vaccinia of Ankara (MVA), expressing MUC1 as well as… (More)
Is this relevant?
2012
2012
Several immunotherapy drugs are today tested in this disease in advanced stages of development. TG4010 (Transgene SA) is one of… (More)
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer (NSCLC). TG4010 is a targeted… (More)
Is this relevant?
2010
2010
MUC1 over-expression in renal clear-cell carcinoma (RCC) is associated with poor prognosis. This phase II study determined the… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2009
2009
3027 Background: TG4010 is a targeted immunotherapy product. It was tested in combination with first-line chemotherapy in a… (More)
Is this relevant?
2008
2008
BACKGROUND TG4010 is a recombinant viral vector expressing both the tumor-associated antigen MUC1 and Interleukine-2. This vector… (More)
Is this relevant?
2008
2008
Purpose: TG4010 is a recombinant MVA vector expressing the tumor-associated antigen MUC1 and IL2. We explored the effect two… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2007
2007
Vaccines are well known in the context of prevention of diseases caused by infectious agents. Current research is now aimed at… (More)
Is this relevant?
2003
2003
BACKGROUND The MUC1 protein is a highly glycosylated mucin normally found at the apical surface of mucin-secreting epithelial… (More)
Is this relevant?